Clinical Study Vestnik otorinolaringologii 1989

Our experience in the hyperbaric oxygenation treatment of patients with acute sensorineural hearing disorder of vascular etiology.

Guseĭnov NM, Konstantinova NP, Lukich VL, Mel'nikova LN, Vernekin EB — Vestnik otorinolaringologii, 1989

View Original on PubMed PMID 2800132

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the optimal timing of hyperbaric oxygenation (HBO) relative to drug therapy in 40 patients with acute neurosensory hearing loss of vascular origin.

What They Found

They found that patients receiving hyperbaric oxygenation (HBO) immediately after drug administration (Group 2) experienced twice as many good effects compared to those receiving HBO before drugs (Group 1). This suggests that administering drugs before HBO helped mitigate HBO's vasoconstrictive side effects.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The study's limitations include a small sample size, lack of specific outcome measures, and limited methodological details provided in the abstract.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Clinical Study
Category	Sudden Hearing Loss
Source	Pubmed
PubMed ID	2800132
Year Published	1989
Journal	Vestnik otorinolaringologii
MeSH Terms	Adult; Cerebrovascular Disorders; Female; Hearing Loss, Sensorineural; Humans; Hyperbaric Oxygenation; Male; Middle Aged

Related Research

JAMA Otolaryngol | 2022 Meta-Analysis ★

Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: a systematic review and meta-analysis

Joshua TG, Ayub A, Bhatt J, et al.

Otolaryngol Head Neck Surg | 2019 Clinical Guideline

Clinical practice guideline: sudden hearing loss (update)

Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al.

Eur Arch Otorhinolaryngol | 2015 Prospective Study

Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study

Pezzoli M, Magnano M, Maffi L, et al.

Audiol Neurootol | 2022 Prospective Study

Efficacy of Hyperbaric Oxygen on Idiopathic Sudden Sensorineural Hearing Loss and Its Correlation with Treatment Course: Prospective Clinical Research.

Huang C, Liu W, Zhang Z, et al.

Cochrane | 2012 Cochrane Review

Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus

Bennett MH, Kertesz T, Perleth M, et al.

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

See all Sudden Hearing Loss research

View on PubMed Back to Research Library

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology